Status:
UNKNOWN
Thyroid Dysfunction and Dyslipidemia in Patients With Chronic Kidney Diseases
Lead Sponsor:
Assiut University
Conditions:
CKD
Eligibility:
All Genders
1-60 years
Brief Summary
Early diagnosis of thyroid and lipid disorders by regular screening, and treatment of such disorders in CKD patients may be highly beneficial to slow progression of CKD. The study will be conducted to...
Detailed Description
Chronic kidney disease\[CKD\] is becoming a serious health problem.The number of people with impaired renal function is rapidly rising, especially in industrialized countries. It is increasing rapidly...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with CKD stage (1-5).
- Not known thyroid disorders.
- Not in lipid lowering agents.
- Exclusion Criteria:
- Patients with known thyroid disorders, on medication affecting thyroid function and lipid lowering agents are excluded from the study.
- CKD patients who were or underwent previous dialysis.
- Nephrotic syndrome.
- Obesity.
- Patients on estrogens, corticosteroids, antithyroid drugs, dietary supplements.
- Pregnant woman
Exclusion
Key Trial Info
Start Date :
September 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03277911
Start Date
September 10 2017
End Date
August 30 2019
Last Update
September 11 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.